PLPC Stock Cash Flow Statements

Preformed Line Products Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Preformed Line Products Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2003-09-30

operating activities
net income	12,700,000	11,553,000	10,445,000	7,696,000	9,367,000	9,603,000	6,309,000	15,145,000	20,464,000	21,419,000	16,488,000	11,889,000	13,721,000	12,301,000	8,951,000	10,702,000	8,891,000	7,177,000	2,658,000	12,962,000	10,488,000	3,653,000	5,603,000	8,043,000	7,866,000	1,824,000	5,263,000	9,055,000	6,735,000	5,528,000	702,000	6,278,000	4,156,000	1,518,000	5,101,000	4,741,000	2,755,000	2,658,000	3,045,000	206,000	3,680,000	-256,000	2,488,000	-510,000
adjustments to reconcile net income to net cash from operations:
depreciation and amortization	5,686,000	5,397,000	4,848,000	5,322,000	5,246,000	5,414,000	5,312,000	4,638,000	4,689,000	4,275,000	6,242,000	3,314,000	3,853,000	3,021,000	5,009,000	3,723,000	3,687,000	3,145,000	3,758,000	3,419,000	3,304,000	3,357,000	3,904,000	3,305,000	3,399,000	3,140,000	3,149,000	2,771,000	3,259,000	3,265,000	3,682,000	3,235,000	2,901,000	2,972,000	3,394,000	3,000,000	2,892,000	2,710,000	2,438,000	2,898,000	2,946,000	3,250,000	3,273,000	1,916,000
deferred income taxes	-327,000	-479,000	4,096,000	-1,099,000	-1,527,000	-386,000	605,000	-826,000	-481,000	-1,530,000	-1,507,000	1,442,000	-2,028,000	-563,000	5,857,000	-888,000	-3,346,000	4,921,000	-4,444,000	387,000	-486,000	1,163,000	229,000	-791,000	-808,000	96,000	794,000	-18,000	-308,000	-154,000	2,579,000	647,000	-501,000	-289,000	3,393,000	-329,000	-792,000	-23,000	975,000	-810,000	108,000	-1,217,000	-1,330,000	1,482,000
share-based compensation expense	1,706,000	892,000	1,463,000	632,000	934,000	383,000	858,000	1,299,000	1,725,000	1,066,000	1,187,000	1,496,000	890,000	1,023,000	872,000	1,364,000	893,000	1,034,000	1,043,000	1,458,000	612,000	976,000	1,052,000	1,388,000	1,028,000	928,000	1,935,000	584,000	986,000	731,000	868,000	1,047,000	579,000	561,000	439,000	421,000	143,000	363,000	794,000	-982,000	-53,000	489,000	754,000
gain on sale of property and equipment	19,000	-37,000	191,000				-21,000	-2,501,000	28,000	16,000		11,000	-50,000	-792,000		-12,000			1,093,000			0	57,000	-47,000	33,000	-33,000			-68,000	-31,000			-6,000	-7,000									-1,000
other	1,271,000	-228,000	-171,000	532,000	-763,000	1,230,000	-5,783,000	2,122,000	2,154,000	1,942,000	-100,000	-467,000
changes in operating assets and liabilities	5,873,000	-11,443,000		-3,630,000	15,046,000	-8,648,000						-8,744,000	-17,624,000	-17,420,000
net cash from operating activities	26,928,000	5,655,000	24,067,000	9,366,000	28,294,000	5,753,000	19,288,000	42,504,000	20,420,000	25,430,000	17,031,000	15,299,000	-1,002,000	-5,175,000	9,512,000	10,025,000	825,000	13,236,000	8,085,000	24,373,000	12,239,000	-3,055,000	6,548,000	14,834,000	5,334,000	501,000	15,889,000	-592,000	8,706,000	-1,027,000	12,117,000	19,694,000	3,588,000	-1,569,000	4,938,000	11,000,000	8,842,000	1,194,000	12,357,000	216,000	7,054,000	602,000	4,172,000
investing activities
capital expenditures	-8,378,000	-10,976,000	-3,431,000	-3,574,000	-3,728,000	-3,918,000	-8,214,000	-9,941,000	-8,826,000	-8,351,000	-15,423,000	-11,366,000	-5,799,000	-8,010,000	-5,779,000	-5,267,000	-3,869,000	-3,469,000	-350,000	-12,399,000	-5,823,000	-5,997,000	-7,517,000	-9,967,000	-9,587,000	-2,396,000	-2,236,000	-1,719,000	-2,874,000	-2,699,000	-3,401,000	-3,278,000	-2,337,000	-2,217,000	-3,028,000	-2,020,000	-14,169,000	-5,508,000	-4,045,000	-2,069,000	-2,368,000	-2,272,000	-3,178,000	-1,128,000
free cash flows	18,550,000	-5,321,000	20,636,000	5,792,000	24,566,000	1,835,000	11,074,000	32,563,000	11,594,000	17,079,000	1,608,000	3,933,000	-6,801,000	-13,185,000	3,733,000	4,758,000	-3,044,000	9,767,000	7,735,000	11,974,000	6,416,000	-9,052,000	-969,000	4,867,000	-4,253,000	-1,895,000	13,653,000	-2,311,000	5,832,000	-3,726,000	8,716,000	16,416,000	1,251,000	-3,786,000	1,910,000	8,980,000	-5,327,000	-4,314,000	8,312,000	-1,853,000	4,686,000	-1,670,000	994,000
proceeds from the sale of property and equipment	6,000	91,000	-39,000	128,000	128,000	3,237,000	125,000	2,377,000	5,000	124,000	12,000	0	0	3,157,000	109,000	9,000	19,000	4,000	10,525,000				6,000	48,000			192,000	0	3,000	0	90,000	51,000	-16,000	17,000	9,000	0	0	61,000	12,000	391,000	-44,000	570,000	19,000	10,000
proceeds from sale of investments	0	1,679,000
purchases of investments	0	-451,000
acquisition of businesses, net of cash							0	0	1,979,000	-14,068,000	-3,245,000	0	0	-12,990,000
net cash from investing activities	-12,552,000	-9,657,000	-4,631,000	-3,446,000	-3,600,000	-681,000	-8,089,000	-7,564,000	-6,842,000	-22,295,000	-18,656,000	-11,366,000	-5,799,000	-10,934,000	-5,670,000	-5,258,000	-3,850,000	-3,465,000	10,175,000	-12,399,000	-5,823,000	-5,997,000	-7,511,000	-9,839,000	-18,388,000	-13,065,000	-2,044,000	-1,719,000	-3,253,000	-7,007,000	-1,932,000	-2,338,000	2,019,000	351,000	-5,519,000	-2,020,000	-18,699,000	-2,231,000	-2,651,000	-2,902,000	-5,884,000	575,000	-3,142,000
financing activities
(payments) proceeds of notes payable to banks							-4,289,000	-2,549,000
proceeds from long-term debt	2,209,000	8,628,000	2,387,000	40,924,000	19,867,000	33,232,000	37,456,000	27,533,000	53,794,000	50,389,000	58,052,000	43,612,000	33,394,000	49,958,000	29,944,000	26,021,000	27,712,000	15,242,000	22,058,000	27,626,000	16,218,000	24,945,000	22,306,000	15,094,000	22,504,000	33,132,000	18,542,000
payments of long-term debt	-786,000	-777,000	-8,058,000	-45,856,000	-43,150,000	-33,069,000	-35,214,000	-50,682,000	-49,650,000	-50,633,000	-47,059,000	-43,930,000	-35,446,000	-29,494,000	-31,907,000	-28,601,000	-25,923,000	-27,106,000	-37,390,000	-35,976,000	-19,065,000	-17,652,000	-22,546,000	-15,997,000	-8,227,000	-17,354,000	-26,201,000	-26,865,000	-21,318,000	-11,112,000	-15,229,000	-17,281,000	-18,316,000	-13,155,000	-15,092,000	-13,788,000	-17,188,000	-11,674,000	-11,907,000	-12,425,000	-13,740,000	-13,868,000	-15,707,000
dividends paid	-988,000	-1,164,000	-979,000	-983,000	-984,000	-1,130,000	-980,000	-983,000	-989,000	-1,154,000	-1,014,000	-1,024,000	-1,030,000	-1,031,000	-1,034,000	-980,000	-983,000	-1,131,000	-996,000	-1,015,000	-998,000	-1,175,000	-1,004,000	-1,006,000	-1,177,000	-1,043,000	-967,000	-1,056,000	-1,057,000	-1,008,000	-950,000	-1,057,000	-1,055,000	-1,037,000	-1,039,000	-1,029,000	-1,046,000	-1,056,000	-1,215,000	-845,000	-1,221,000	-1,110,000	-1,100,000	-1,157,000
proceeds from issuance of common shares	92,000	68,000	54,000	99,000	1,000	60,000	144,000	1,356,000	309,000	355,000	328,000	363,000	1,000	116,000	15,000	30,000	364,000	0	78,000	-92,000	30,000	236,000	184,000	29,000			-924,000	894,000			1,962,000	0			-130,000	268,000	110,000	0	0	20,000	20,000	40,000	-1,000
stock incentive plan payments	0	-3,799,000
purchase of common shares for treasury	0	-131,000	-113,000	0			0	-612,000	0	-116,000	-92,000	0	0	-66,000	-1,000	0	-176,000	0	-4,000	-1,219,000	-3,011,000	-1,602,000	-403,000	-702,000	-1,456,000	-239,000	-36,000	-45,000	0	-110,000	0	236,000	-238,000	0	-193,000	-883,000	-1,405,000	-627,000	-3,625,000	-2,174,000	-130,000	-74,000	0
purchase of common shares for treasury from related parties	-2,351,000	-881,000	-238,000	-2,233,000	-456,000	-5,452,000	-493,000	-7,947,000	-6,100,000	-3,624,000	-1,440,000	-2,140,000	0	-1,729,000	-1,000	-543,000	-870,000	-3,678,000	-1,248,000	0	0	-2,378,000	-1,922,000	-49,000	0	-2,055,000	-3,000	-2,266,000	-982,000	-723,000	-6,987,000	-1,486,000	105,000	-107,000	-474,000	-1,455,000	0	-33,000	-335,000	-1,075,000	0	-140,000	0
net cash from financing activities	-4,768,000	-22,000	-7,001,000	-7,298,000	-21,838,000	-11,666,000	-3,376,000	-33,884,000	-2,355,000	-9,307,000	7,897,000	-883,000	431,000	15,098,000	-4,118,000	-380,000	1,752,000	-20,484,000	-16,679,000	-7,182,000	-5,015,000	5,711,000	-2,262,000	-4,687,000	13,529,000	11,134,000			-7,017,000	8,286,000	-3,891,000	-6,897,000	-9,232,000	469,000	-2,144,000	-4,025,000	7,899,000	2,659,000	-5,804,000	-4,156,000	-688,000	-2,009,000	-771,000
effects of exchange rate changes on cash, cash equivalents and restricted cash	2,465,000	1,615,000	-2,689,000	1,452,000	-1,291,000	-1,154,000	2,048,000	-480,000	146,000	724,000	18,000	-2,204,000	1,843,000	-765,000																939,000
net increase in cash, cash equivalents and restricted cash							9,871,000	576,000							-1,920,000				3,927,000				-2,222,000			-138,000	9,549,000			1,191,000
cash, cash equivalents and restricted cash at beginning of year	0	57,244,000	0	0	0	53,607,000	0	0	0	37,239,000	0	0	0	36,406,000	0	0	0	45,175,000	0	0	0	39,263,000	0	0	0	43,910,000	20,000	0	0	45,579,000
cash, cash equivalents and restricted cash at end of period	12,073,000	54,835,000		74,000	1,565,000	45,859,000		576,000				846,000	-4,527,000	34,630,000		4,872,000	-1,231,000	34,685,000		4,742,000	2,389,000	34,117,000		-100,000	-2,187,000	43,772,000		-7,356,000	-5,073,000	46,770,000
payments of notes payable to banks		-1,966,000				-5,307,000
net decrease in cash, cash equivalents and restricted cash		-2,409,000		74,000	1,565,000	-7,748,000				-5,448,000		846,000	-4,527,000	-1,776,000			-1,231,000	-10,490,000			2,389,000	-5,146,000
benefit from accounts receivable allowances															947,000	902,000	656,000	390,000	679,000	696,000	254,000	424,000	805,000	590,000	297,000	440,000	353,000	278,000	374,000	201,000	239,000	149,000	490,000	287,000	1,486,000	566,000	142,000	-10,000	548,000	93,000	274,000	46,000	438,000
benefit from inventory reserves															2,480,000	-461,000	222,000	811,000	317,000	717,000	636,000	365,000	-5,000	393,000	808,000	87,000	674,000	273,000	586,000	869,000	-41,000	524,000	265,000	457,000	1,430,000	442,000	855,000	9,000	1,472,000	221,000	576,000	208,000	1,006,000
goodwill impairment											0
gain from company owned life insurance policy
loss on exit of business											0	-171,000	207,000	989,000
accounts receivable															7,906,000	-6,036,000	-10,332,000	-3,114,000	7,081,000	-1,907,000	-10,521,000	-5,192,000	3,088,000	3,297,000	-16,553,000	391,000	12,972,000	-9,876,000	-4,960,000	-2,635,000	6,039,000	40,000	-9,140,000	-6,144,000	2,451,000	-4,859,000	2,484,000	-2,368,000	909,000	-6,522,000	-304,000	2,952,000	2,979,000
inventories															-9,452,000	-5,232,000	-4,316,000	-5,154,000	107,000	4,753,000	-1,299,000	-3,481,000	-2,564,000	-2,777,000	-1,738,000	-2,376,000	-3,791,000	368,000	-5,462,000	-4,818,000	-2,797,000	50,000	2,056,000	-1,517,000	-3,503,000	-1,266,000	-3,242,000	1,657,000	616,000	-870,000	-1,930,000	-113,000	-2,843,000
prepaid expenses															-6,955,000	-1,777,000	-2,376,000	8,134,000
trade accounts payable and accrued liabilities																6,544,000	8,245,000	795,000		4,845,000	6,822,000	-2,112,000		2,826,000	7,284,000	1,481,000		5,138,000	6,844,000	-3,112,000		6,812,000	2,245,000	-210,000		8,674,000	3,218,000	-2,331,000
accrued income and other taxes															273,000
contributions to company pension plan															0				0				0				0
proceeds from company owned insurance policy
proceeds (payments) of notes payable to banks			-54,000	751,000
cash, cash equivalents and restricted cash at end of year										31,791,000
(gain) loss on sale of property and equipment					-9,000	-1,843,000																					-9,000
changes in operating assets and liabilities:								22,627,000	-8,159,000	-1,758,000
proceeds from company owned life insurance policy
payments on notes payable to banks										-4,524,000
increase in notes payable to banks											-878,000	2,236,000			-1,134,000	3,693,000	1,628,000	-3,811,000	823,000	3,494,000	1,811,000	3,337,000	1,123,000	-2,056,000	1,885,000	-1,307,000	5,315,000	1,076,000	1,119,000	936,000			697,000	-695,000	1,023,000	-509,000	-14,000	351,000	-629,000	-1,029,000	639,000	244,000	753,000	-3,000
adjustments to net cash from operations:
gain from company-owned life insurance policy												0	0	-4,364,000
proceeds from company-owned life insurance policy												0	0	6,909,000
other – net														630,000
decrease in notes payable to banks														-2,656,000
other - net															338,000	0	0	318,000	15,000	321,000	34,000	-364,000	327,000	-102,000	204,000	-137,000	40,000	98,000	-129,000	183,000	-131,000	68,000	83,000	193,000	126,000	-1,000	403,000	9,000	-304,000	275,000	91,000	5,000	-4,000
changes in operating assets and liabilities assets:
trade accounts payables and accrued liabilities																																							-1,754,000	4,707,000	6,818,000	-4,119,000	140,000
purchase of marketable securities																			0	0	0	0	0	0	0	-496,000	0	0	-382,000	-4,308,000
proceeds from sale of marketable securities
purchase of company owned life insurance policies
effects of exchange rate changes on cash and cash equivalents															-1,644,000	485,000	42,000	223,000	2,346,000	-50,000	988,000	-1,805,000	1,003,000	-408,000	-2,662,000	1,292,000	-22,000	1,001,000			-1,099,000	702,000	593,000	1,046,000	522,000	-158,000	-1,262,000	-652,000	-379,000	2,982,000	-282,000	1,719,000	662,000	228,000
income taxes - net																	-33,000	-4,782,000		769,000	423,000	-328,000		1,669,000	986,000	-775,000		-3,031,000	572,000	1,733,000		610,000	717,000	1,997,000
loss on sale of property and equipment																		-16,000
income taxes
proceeds from marketable securities																				0				0				0
purchase of company owned life insurance policy																				0				0			0	0
acquisition, net of cash acquired																				0	0	0				-10,173,000
fixed-term deposits																											0	0	0	0
acquisition of businesses, net of cash acquired																								80,000
excess tax benefits from share-based awards																																					-16,000	8,000	40,000	0	0	-20,000	63,000
net cash (used in) financing activities
proceeds from the issuance of long-term debt																													14,969,000	20,303,000	17,024,000	13,519,000	9,575,000	15,463,000	13,761,000	13,381,000	27,426,000	15,706,000	11,947,000	13,372,000	13,744,000	12,879,000	15,347,000
business acquisitions, net of cash acquired																																							0	0	0	0	0
restricted cash and purchase of fixed-term deposits																																			-2,500,000	0	-4,530,000	3,216,000	1,382,000	-1,224,000	-3,472,000	2,277,000
net increase in cash and cash equivalents																															5,195,000			297,000	-2,203,000	4,797,000	-3,220,000	970,000	3,523,000	-3,860,000	200,000	887,000	921,000
cash and cash equivalents at beginning of year																															0	0	0	30,737,000	0	0	0	30,393,000	0	0	0	29,643,000	0	0
cash and cash equivalents at end of year
restricted cash and maturity (purchase) of fixed-term deposits - net																																889,000	4,372,000	2,551,000
excess tax expenses from share-based awards																																0	0	0
cash and cash equivalents at end of period																																11,161,000	-3,032,000	31,034,000		4,797,000	-3,220,000	31,363,000		-3,860,000	200,000	30,530,000
net decrease in cash and cash equivalents
excess tax benefits (expenses) from share-based awards
income taxes payable																																				1,360,000	-1,499,000	-196,000	-2,342,000	1,187,000	-877,000	-2,006,000	-1,290,000
earn-out consideration payments																																											0
purchase of fixed term deposits
fixed term deposits
net investment in life insurance
restricted cash and long-term term deposits
earn-out consideration payment
other—net
restricted cash
unrealized foreign currency gain on hedge contract
other — net																																												-42,000
less: income from discontinued operations
income from continuing operations
gain on acquisition of business
proceeds from the sale of discontinued operations
proceeds on life insurance
payments on life insurance
net cash from discontinued operations
operating cash flows
investing cash flows
business acquisitions																																												-10,000
cash and cash equivalents at beginning of period
minority interest
adjustments to reconcile net income to net cash from operating activities:
stock-based compensation expense
excess tax benefits from stock-based awards
business acquisitions — net of cash acquired
dividends paid — net
financing cash flows
changes in operating assets and liabilities, net of business acquisitions:
stock based compensation expense
business acquisitions, net of cash acquired of 187
issuance of common shares																																												0
decrease in cash and cash equivalents
excess tax benefits from stock based awards
increase in cash and cash equivalents																																												869,000
changes in operating assets and liabilities, net of acquisitions:
business acquisitions, net of cash received
changes in operating assets and liabilities, net of acquisition:
translation adjustment
earnings of joint ventures																																												59,000
dividends received from joint ventures																																												788,000
gain on sale of joint venture
proceeds from the sale of equity investment
proceeds (payments) on life insurance — net
earnings of joint venture
dividends received from joint venture
see notes to consolidated financial statements.
asset impairment
noncash abandonment/realignment charges
cash surrender value of life insurance
cumulative translation adjustment
proceeds from the issuance of debt																																												658,000
issuance (purchase) of common shares
adjustments to reconcile net income to net cash from operations
noncash abandonment charges
payments of debt																																												-1,947,000

We provide you with 20 years of cash flow statements for Preformed Line Products stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Preformed Line Products stock. Explore the full financial landscape of Preformed Line Products stock with our expertly curated income statements.

The information provided in this report about Preformed Line Products stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.